| Followers | 40 |
| Posts | 1956 |
| Boards Moderated | 0 |
| Alias Born | 03/24/2014 |
Wednesday, January 05, 2022 9:41:03 AM
I am of the opinion this is what's happening with NWBO but certainly don't have all the details.
-The UK decided to join the project as the Medicines and Healthcare products Regulatory Agency (MHRA) will lose the ability to collaborate with EU countries on drug assessments next year. MHRA’s participation will potentially accelerate access to some cancer drugs in the UK by allowing companies to gain approval while targeting the far larger US market.
-Project Orbis is a programme coordinated by the US Food and Drug Administration
(FDA) to review and approve promising cancer treatments. It provides a framework for
concurrent submission and review of oncology products among international partners.
It aims to deliver faster patient access to innovative cancer treatments with potential
benefits over existing therapies across the globe.
The MHRA participate fully in the scheme since 1 January 2021. While the FDA serves
as the primary coordinator for application selection and review, Project Orbis Partners
(POPs) may propose products for inclusion in the scheme.
It involves the regulatory authorities of the following countries:
• Australia (TGA)
• Canada (Health Canada)
• United Kingdom (MHRA)
• Singapore (HSA)
• Switzerland (Swissmedic)
• Brazil (ANVISA)
Each country remains fully independent on their final regulatory decision. Applications
submitted to the MHRA within a Project Orbis procedure are national (GB only)
marketing authorisation applications and variations.
The objective of Project Orbis is to eliminate this delay and allow earlier access to products in countries where regulatory submissions usually lag behind those made in the US. Essentially, one regulatory submission can now yield approvals in multiple different countries.
Look at this Document by FDA for questions on SAP and Orbis Timelines.
https://www.fda.gov/about-fda/oncology-center-excellence/real-time-oncology-review
8.The protocol and amendments (a list of major changes for each amendment), SAP, and DMC charter and DMC minutes
Recent NWBO News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2025 09:23:24 PM
FEATURED Cannabix Technologies Announces Commercial Launch of Marijuana Breath Test (MBT) • Mar 16, 2026 8:37 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
